NanoValent Pharmaceuticals Inc (NVP) is a very capital efficient, virtually dispersed, company developing novel ethical therapeutics based on the utility of specific polymerizable lipids. NVP is working with USC CHLA and Boston University to create products and patents, achieve scientific proof in principle with commercially validated controls, secure global rights, and advance products for commercial development.